Abstract: A system and method for growing and maintaining biological material including producing a protein associated with the tissue, selecting cells associated with the tissue, expanding the cells, creating at least one tissue bio-ink including the expanded cells, printing the at least one tissue bio-ink in at least one tissue growth medium mixture, growing the tissue from the printed at least one tissue bio-ink, and maintaining viability of the tissue.

Abstract: Methods and apparatuses for reducing step loads of processors are disclosed. Method embodiments comprise examining a number of instructions to be processed by a processor to determine the types of instructions that it has, calculating power consumption by in an execution period based on the types of instructions, and limiting the execution to a subset of instructions of the number to control the quantity of power for the execution period. Some embodiments may also create artificial activity to provide a minimum power floor for the processor. Apparatus embodiments comprise instruction type determination logic to determine types of instructions in an incoming instruction stream, a power calculator to calculate power consumption associated with processing a number of instructions in an execution period, and instruction throttling logic to control the power consumption by limiting the number of instructions to be processed in the execution period.

Abstract: Methods and apparatuses for reducing step loads of processors are disclosed. Method embodiments comprise examining a number of instructions to be processed by a processor to determine the types of instructions that it has, calculating power consumption by in an execution period based on the types of instructions, and limiting the execution to a subset of instructions of the number to control the quantity of power for the execution period. Some embodiments may also create artificial activity to provide a minimum power floor for the processor. Apparatus embodiments comprise instruction type determination logic to determine types of instructions in an incoming instruction stream, a power calculator to calculate power consumption associated with processing a number of instructions in an execution period, and instruction throttling logic to control the power consumption by limiting the number of instructions to be processed in the execution period.

Abstract: Methods and apparatuses for reducing step loads of processors are disclosed. Method embodiments comprise examining a number of instructions to be processed by a processor to determine the types of instructions that it has, calculating power consumption by in an execution period based on the types of instructions, and limiting the execution to a subset of instructions of the number to control the quantity of power for the execution period. Some embodiments may also create artificial activity to provide a minimum power floor for the processor. Apparatus embodiments comprise instruction type determination logic to determine types of instructions in an incoming instruction stream, a power calculator to calculate power consumption associated with processing a number of instructions in an execution period, and instruction throttling logic to control the power consumption by limiting the number of instructions to be processed in the execution period.

Abstract: Method of treating or preventing the inflammatory response of colitis in a subject comprising administering to the subject an effective amount of a substance that modulates IL-13 activity (FIG. 3). The invention also provides a method of treating or preventing the inflammatory response of colitis in a subject comprising administering to the subject an effective amount of a substance that modulates NK-T cell activity. The invention also provides for the screening of substances that treat or prevent the inflammatory response of colitis.

Abstract: Methods and apparatuses for reducing step loads of processors are disclosed. Method embodiments comprise examining a number of instructions to be processed by a processor to determine the types of instructions that it has, calculating power consumption by in an execution period based on the types of instructions, and limiting the execution to a subset of instructions of the number to control the quantity of power for the execution period. Some embodiments may also create artificial activity to provide a minimum power floor for the processor. Apparatus embodiments comprise instruction type determination logic to determine types of instructions in an incoming instruction stream, a power calculator to calculate power consumption associated with processing a number of instructions in an execution period, and instruction throttling logic to control the power consumption by limiting the number of instructions to be processed in the execution period.

Abstract: The use of an agent that selectively modulates cross-linking of biliary glycoprotein polypeptides for the preparation of a pharmaceutical composition for preventing or treatment of a mammal subject afflicted with an inflammatory disease is provided. In particular, a method for preventing or treatment of a mammal subject afflicted with rheumatoid arthritis or multiple sclerosis, comprising the step of administering to a mammal in need thereof a therapeutic effective amount of a fusion protein of a fragment of biliary glycoprotein and a fragment of an immunoglobulin is described.

Abstract: Methods and apparatuses for reducing step loads of processors are disclosed. Method embodiments comprise examining a number of instructions to be processed by a processor to determine the types of instructions that it has, calculating power consumption by in an execution period based on the types of instructions, and limiting the execution to a subset of instructions of the number to control the quantity of power for the execution period. Some embodiments may also create artificial activity to provide a minimum power floor for the processor. Apparatus embodiments comprise instruction type determination logic to determine types of instructions in an incoming instruction stream, a power calculator to calculate power consumption associated with processing a number of instructions in an execution period, and instruction throttling logic to control the power consumption by limiting the number of instructions to be processed in the execution period.

Abstract: Methods and apparatuses for reducing step loads of processors are disclosed. Method embodiments comprise examining a number of instructions to be processed by a processor to determine the types of instructions that it has, calculating power consumption by in an execution period based on the types of instructions, and limiting the execution to a subset of instructions of the number to control the quantity of power for the execution period. Some embodiments may also create artificial activity to provide a minimum power floor for the processor. Apparatus embodiments comprise instruction type determination logic to determine types of instructions in an incoming instruction stream, a power calculator to calculate power consumption associated with processing a number of instructions in an execution period, and instruction throttling logic to control the power consumption by limiting the number of instructions to be processed in the execution period.

Abstract: The use of an agent that selectively modulates cross-linking of biliary glycoprotein polypeptides for the preparation of a pharmaceutical composition for preventing or treatment of a mammal subject afflicted with an inflammatory disease is provided. In particular, a method for preventing or treatment of a mammal subject afflicted with rheumatoid arthritis or multiple sclerosis, comprising the step of administering to a mammal in need thereof a therapeutic effective amount of a fusion protein of a fragment of biliary glycoprotein and a fragment of an immunoglobulin is described.

Abstract: The present invention relates in general to methods and products for initiating an immune response against an antigen, and in particular relates to transepithelial delivery of antigens to provoke tolerance and immunity. The present invention further relates to methods and products for the transepithelial delivery of therapeutics. In particular, the invention relates to methods and compositions for the delivery of therapeutics conjugated to a FcRn binding partner to intestinal epithelium, mucosal epithelium and epithelium of the lung. The present invention further relates to the synthesis, preparation and use of the FcRn binding partner conjugates as, or in, pharmaceutical compositions for oral systemic delivery of drugs and vaccines.

Abstract: The present invention is generally drawn to novel isolated therapeutic agents, termed resolvins, generated from the interaction between a dietary omega-3 polyunsaturated fatty acid (PUFA) such as eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA), oxygenases and the analgesic aspirin (ASA). Surprisingly, careful isolation of compounds generated from the combination of components in an appropriate environment provide di- and tri-hydroxy containing derivatives of EPA and DHA containing compounds having unique structural and physiological properties. The present invention therefore provides for many new useful therapeutic di- and tri-hydroxy derivatives of EPA or DHA (resolvins of the E series and D series) that diminish, prevent, or eliminate gastrointestinal conditions, for example, such as colitis. The present invention also provides methods of use, methods of preparation, and packaged pharmaceuticals for use as medicaments for the compounds disclosed throughout the specification.

Abstract: The present invention relates to methods and products for the transepithelial systemic delivery of therapeutics. In particular, the invention relates to methods and compositions for the systemic delivery of therapeutics by administering an aerosol containing antibodies or conjugates of a therapeutic agent with an FcRn binding partner to epithelium of central airways of the lung. The methods and products are adaptable to a wide range of therapeutic agents, including proteins and polypeptides, nucleic acids, drugs, and others. The methods and products have the advantage of not requiring administration to the deep lung in order to effect systemic delivery.

Abstract: Method of treating or preventing the inflammatory response of colitis in a subject comprising administering to the subject an effective amount of a substance that modulates IL-13 activity (FIG. 3). The invention also provides a method of treating or preventing the inflammatory response of colitis in a subject comprising administering to the subject an effective amount of a substance that modulates NK-T cell activity. The invention also provides for the screening of substances that treat or prevent the inflammatory response of colitis.

Abstract: The invention provides a method of inhibiting inflammation in a mammal, by administering to the mammal composition containing a compound which inhibits the expression or activity of a microsomal triglyceride transfer protein.

Abstract: The invention relates to compositions which bind T cell inhibitory receptor molecules and modulate T cell activity, and methods of using such compositions. Such compositions include biliary glycoprotein binding agents. Methods for modulating killer T cell activities, including cytotoxicity and proliferation also are provided.

Abstract: The invention provides a method of inhibiting inflammation in a mammal, by administering to the mammal composition containing a compound which inhibits the expression or activity of a microsomal triglyceride transfer protein.